Kodiak Sciences (KOD) Common Equity (2017 - 2026)
Kodiak Sciences' Common Equity was $61.1 million in Q2 2026, down 13.1% from $70.29 million a year earlier and down 45.5% from the prior quarter.
Kodiak Sciences (KOD) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Kodiak Sciences came in at $157.38 million, up 4.7% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -28.8% (FY2020 to FY2025).
- In earlier years, Common Equity was $150.29 million in FY2024 (-43.5%), $265.78 million in FY2023 (-39.1%), $436.17 million in FY2022 (-34.2%) and $663.32 million in FY2021 (-22.9%).
- Quarterly Common Equity has moved between $23.69 million (Q3 2025) and $726.32 million (Q3 2021) over five years.
- Compared with a year earlier, Common Equity was higher in two of the last eight quarters, with an average decline of 37.1%.
- The best year-over-year quarter for Common Equity over five years was Q3 2021 (growth of 157.8%); the worst was Q3 2025 (a decline of 87.2%).
- Per Business Quant data, KOD's Common Equity in the three quarters before Q2 2026 was $112.1 million (Q1 2026), $157.38 million (Q4 2025) and $23.69 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Kodiak Sciences | 5.65 Bn | 5.65 Bn | - | 61.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.10 Mn |
| Mar 31, 2026 | 112.10 Mn |
| Dec 31, 2025 | 157.38 Mn |
| Sep 30, 2025 | 23.69 Mn |
| Jun 30, 2025 | 70.29 Mn |
| Mar 31, 2025 | 108.84 Mn |
| Dec 31, 2024 | 150.29 Mn |
| Sep 30, 2024 | 185.37 Mn |
| Jun 30, 2024 | 214.51 Mn |
| Mar 31, 2024 | 241.19 Mn |
| Dec 31, 2023 | 265.78 Mn |
| Sep 30, 2023 | 302.42 Mn |
| Jun 30, 2023 | 338.48 Mn |
| Mar 31, 2023 | 392.59 Mn |
| Dec 31, 2022 | 436.17 Mn |
| Sep 30, 2022 | 479.53 Mn |
| Jun 30, 2022 | 530.93 Mn |
| Mar 31, 2022 | 597.38 Mn |
| Dec 31, 2021 | 663.32 Mn |
| Sep 30, 2021 | 726.32 Mn |
Kodiak Sciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=KOD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "KOD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=KOD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();